TTI-0102 for Veterans With TBI

NCT04262895 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

FED

Sponsor class

Stopped Funding withdrawn due to delay in FDA IND submission

Conditions

Mild to Moderate TBI
Posttraumatic Stress Disorder

Interventions

DRUG: TTI-0102
DRUG: Placebo

Sponsor

VA Office of Research and Development